Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Book our experts as speakers at your event

We regularly present at international clinical events. If you would like one of our experts to speak at your event, please support your enquiry below.

Your enquiry has been sent. A member of our team will be in touch shortly.
Looks like we're having trouble

Meet the Experts

The team at Richmond Pharmacology has extensive knowledge and expertise in every area of Early Phase clinical trials. Our founding Directors are clinical pharmacologists and lead a dedicated, competent, and motivated team of experienced managers and personnel.

Our employees regularly receive high quality training. The rigorous approval process we have in place ensures the highest standard of conduct for studies.

Richmond Pharmacology's reputation extends beyond the boundaries of our London Bridge Unit. Due to our standing within the industry, we have developed partnerships with eminent Professors, Surgeons and Doctors who all contribute to the conduct of our clinical trials.

Key Scientific and Operational Personnel

Dr Jorg Taubel MD, FFPM, FESC
CEO and Founder

Dr Jorg Taubel is a medical practitioner and CEO of Richmond Pharmacology which he co-founded in 2001.

Read biography

Keith Berelowitz MSC
Commercial Director

A scientist by training, Keith has worked in clinical research (academic and commercial) for over 22 years.

Read biography

Dr Ulrike Lorch MD, FRCA, FFPM
Chief Medical Director and Founder

Dr Ulrike Lorch is a co-founder and Chief Medical Director of Richmond Pharmacology and Director of Human Pharmacology at the Faculty of Pharmaceutical Medicine.

Read biography

Dilshat Djumanov MPhil, PhD
Director of Data Science

Dilshat has an in depth knowledge of data management and data analysis for adaptive clinical trials and QTc studies.

Read biography

Emma Akuffo BSC, PhD, MBA
Director of Study Management

Emma oversees the Study Management, Advanced Research Science and Quality Assurance teams at Richmond Pharmacology.

Read biography

Samarjit Singh BSC, MSc
Director of Clinical Operations

Samarjit has been part of the Richmond Pharmacology team over 16 years, during which he held several positions, including his current role as Director of Clinical Operations.

Read biography

Sandra Johnson BSC
Director of Commercial Project Management

Bringing over 20 years of experience in the life science sector, including at Roche and Novartis, Sandra has an extensive understanding of clinical trials.

Read biography

Scientific Advisory Board

Professor Anand
Professor of Neurology

Professor Praveen Anand studied medicine at Cambridge University.

Read biography

Professor Camm
Professor of Cardiology

Professor Camm studied medicine at Guy's Hospital Medical School, London.

Read biography

Professor Kaski
Professor of Cardiology

In 2001, Professor Kaski was awarded the degree of Doctor of Science (DSc) by the University of London.

Read biography

Professor McLean
Professor Emeritus of Toxicology

Professor Andre McLean studied medicine at Oxford and University College Hospital.

Read biography

Professor Oliveira
Professor of Renal Medicine

Professor David Oliveira studied medicine at Cambridge University as well as Westminster Hospital Medical School where he qualified in 1979.

Read biography

External Experts

Professor Dalgliesh
Professor of Oncology

Professor Angus Dalgliesh graduated from University College Hospital, London and obtained an MBBS with an intercalated BSc Hons in Anatomy under Professor J. J. Young, FRS.

Read biography

Professor Axford
Professor of Rheumatology

Professor John Axford studied medicine at University College, London in 1989.

Read biography

Dr Von Oertzen
Consultant Neurologist and Epileptologist

Dr. von Oertzen studied medicine at Rheinische-Friedrich-Wilhelm University, Germany .

Read biography

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more


AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event